 <h1>Morphine liposomal Side Effects</h1><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Interactions</li>
<li>Pregnancy</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p><i>Applies to morphine liposomal: injectable suspension extended release</i></p><h3>General</h3><p>The more commonly reported side effects have included nausea, pruritus, pyrexia, vomiting, hypotension, anemia, headache, constipation, decreased oxygen saturation, urinary retention, and dizziness.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Decreased oxygen saturation</p><p><b>Common</b> (1% to 10%): Hypoxia, respiratory depression, hypercapnia, dyspnea</p><p><b>Postmarketing reports</b>: Severe respiratory depression, involving apnea or respiratory arrest, and cardiac arrest<sup>[Ref]</sup></p><p>Prolonged and serious respiratory depression was reported when administration was associated with subarachnoid puncture.  In these cases, respiratory depression occurred following apparent recovery from anesthesia (within 12 hours of administration).  </p><p></p><p>Four percent of patients receiving this drug in clinical trials required treatment with narcotic antagonists for respiratory depression; 90% of respiratory depression events were reported within the first 24 hours.  Delayed respiratory depression (occurring up to 48 hours postdose) was reported in 2% of patients; 0.6% of patients reported respiratory depression after more than 48 hours.  During the postmarketing period, severe respiratory depression involving apnea or respiratory arrest have been reported following administration of labeled doses.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Postmarketing reports</b>: Central nervous system depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy<sup>[Ref]</sup></p><p>CNS depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy, has been reported.  In most cases, there was concomitant administration of different narcotics or hypnotic/sedative medications in the post-operative period.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hypotension</p><p><b>Common</b> (1% to 10%): Tachycardia, hypertension, bradycardia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Vomiting, constipation, nausea </p><p><b>Common</b> (1% to 10%): Flatulence, paralytic ileus, dyspepsia, abdominal distension<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Pruritus</p><p><b>Common</b> (1% to 10%): Hypoesthesia, increased sweating<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Rigors<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hypokalemia</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety</p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia</p><p><b>Common</b> (1% to 10%): Decreased hematocrit<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary retention</p><p><b>Common</b> (1% to 10%): Bladder spasm, oliguria<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. DepoDur (morphine liposomal)." Endo Laboratories LLC, Chadds Ford, PA. </p><h2>More about morphine liposomal</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: narcotic analgesics</li>
</ul><h3>Consumer resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Pain</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>